keynote delivery at #Ideagoras 2011 “

In health care, patients are often left alone with their therapies. Currently, we see service and marketing in health care efforts using the internet to fill the patients’ most obvious needs. Information services, indication backgrounds, drug information, patient stories, communities around peers, compliance guidelines are all services brought to the patient on a one-to-one basis.
From a health care perspective, these efforts are innovative, but do not present a structural attempt to systematically arrange all or several of the elements that caring for one’s health condition may include.
Setting up and delivering an integrated context for servicing patients’ needs and demands will be more beneficial to patients in coping with their condition, as well as to the stakeholders relating to them in pursuing their health care business.
Originally posted on “Value innovation in medical and life sciences” ; July 30th, 2010

In an era of increasing diversification of print, broadcast and online media outlets, how can life sciences companies maximise the efficiency and impact of their communications channels?
What specific strategies should life sciences companies employ to ensure they get the maximum benefit from digital communications channels such as social networking sites and blogs?

What you may like to prevent just by using social media in health care.
Here’s a Dutch father complaining about the reimbursement of a continuous glucose monitoring system in a national newspaper. For the control of his daughter’s diabetes, who has also a Down syndrome, he is only reimbursed for a normal glucose meter, not the wished for continuous glucose monitoring system.
The father states that the health care insurance company informed him, unsolicited: “We want you to know that continuous monitoring can not be reimbursed.” That’s what it was. He is amazed that the Down condition of his daughter is not a concern to them whatsoever? Shouldn’t it have been taken into account?
..
Origonally posted on “Value innovation in medical and life sciences” ; September 27th, 2009